Hyperthyroidism: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
mNo edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | |||
==Treatment== | ==Treatment== | ||
===Medical=== | ===Medical=== | ||
| Line 4: | Line 6: | ||
==References== | ==References== | ||
<references/> | <references/>[[Category:Suggestion Bot Tag]] | ||
[[Category: | |||
Latest revision as of 11:01, 30 August 2024
Treatment
Medical
For patients treated medically, methimazole is the first choice medication. [1] Methimazole 15 mg by mouth once per day will normalize the free T4 in 86% of patients with less liver toxicity than propylthiouracil.
References
- ↑ Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N (2007). "Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by graves' disease". J. Clin. Endocrinol. Metab. 92 (6): 2157-62. DOI:10.1210/jc.2006-2135. PMID 17389704. PMID 17389704. Research Blogging.